Skip to content

Clinical trials

Phase 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Phase: Phase 3 Country / region: United States Clear all

90 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20007
20011
20025
20031
20044
20054
20064
20076
20088
20092
20103
20113
20124
20132
20144
20151
20161
20173
20192
20211
20221
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed64
Terminated11
Active, not recruiting7
Withdrawn4
Unknown status3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group19
St. Jude Children's Research Hospital7
Fred Hutchinson Cancer Center6
Dana-Farber Cancer Institute4
Memorial Sloan Kettering Cancer Center4
Alliance for Clinical Trials in Oncology3
Jonsson Comprehensive Cancer Center3
Medical College of Wisconsin3
Bristol-Myers Squibb2
Case Comprehensive Cancer Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma90
Leukemia, Myeloid, Acute41
Leukemia39
Burkitt Lymphoma34
Lymphoma, Non-Hodgkin32
Hodgkin Disease29
Leukemia, Lymphocytic, Chronic, B-Cell29
Lymphoma28
Lymphoma, Mantle-Cell27
Lymphoma, Follicular26

Trials

Showing 1 to 25 of 90. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.